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The gap between the demand and availability of donor livers for transplantation has stimulated the use of 
extended-criteria donor livers, including steatotic, elderly, 
and donation after circulatory death (DCD) liver grafts.1 
These types of donor livers, however, have a higher risk 
of developing postoperative complications. Especially 
posttransplant cholangiopathy, or nonanastomotic biliary 
strictures (NAS), occur in 13% to 35% of DCD grafts, 
compared with 1% to 24% of livers donated after brain 
death.2-7 Although the pathogenesis of NAS is not fully 
understood, the degree of histological bile duct injury 
(BDI) at the time of transplantation has been identified 
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as a strong predictor of the development of NAS after 
transplantation.8-10
In an attempt to expand the donor liver pool, research-
ers are increasingly using ex situ machine perfusion of liver 
grafts before transplantation. When performed at 37°C, 
normothermic machine perfusion (NMP) renders the organ 
metabolically active, which allows for viability testing and 
the selection of potentially transplantable organs.11-14 
Currently, criteria for the selection of suitable donor livers 
during NMP include bile production, lactate clearance, vas-
cular flows, macroscopic appearance of the liver, transami-
nase concentration, and pH buffering capacity.11-14 These 
parameters, however, mainly reflect hepatocellular function 
and injury, and do not provide information about cholan-
giocellular function or injury. Identification and determi-
nation of the diagnostic accuracy of biomarkers of BDI is 
clinically relevant as they may provide a missing tool in 
the selection of liver grafts with an anticipated low risk of 
NAS. Low biliary pH, bicarbonate, and high biliary glucose 
during NMP have recently been associated with the devel-
opment of NAS in 3 cases, and with histological bile duct 
stroma necrosis in 5 research livers.14 The authors reported 
that a biliary pH of 7.4 or less during NMP was able to dis-
criminate between these livers, but have provided no other 
cutoff values and have not reported on the implementation 
of these biliary parameters clinically.
Cholangiocytes lining the bile duct lumen and peri-
biliary glands actively contribute to the composition of 
bile by secretion of bicarbonate via cystic fibrosis trans-
membrane regulator (CFTR) and chloride-bicarbonate 
anion exchanger 2 (AE2).15,16 As a result of this, bile 
in the extrahepatic bile duct has a pH ranging between 
7.5 and 8.1 and bicarbonate concentration of 12 to 55 
mmol/L.17,18 Moreover, cholangiocytes actively reabsorb 
glucose from bile via sodium-dependent glucose trans-
porter, SGLT1, expressed on their apical plasma mem-
brane domain, and another glucose transporter, GLUT1, 
on their basolateral domain.19,20 This results in very low 
biliary glucose concentrations under physiological con-
ditions.21,22 These transporters are ATP-dependent, and 
studies have shown that ischemia leads to diminished 
function of SGLT1 in cholangiocytes, with subsequent 
decreased glucose reabsorption.23
To determine the added value of specific biomarkers of 
biliary viability during NMP, we first examined whether 
histological BDI correlates with markers of hepatocellular 
injury. As this correlation was poor, we proceeded to iden-
tify biomarkers of BDI that can be easily assessed point-
of-care. Our aim was to determine the diagnostic accuracy 
of biliary pH, bicarbonate, glucose and lactate dehydro-
genase (LDH) concentration,24-27 to discriminate between 
livers with a high or low degree of BDI.
MATERIALS AND METHODS
Donor Livers
Twenty-three human donor livers that were declined 
for transplantation nationwide and offered for research 
were used to determine suitable biomarkers of BDI during 
NMP in a preclinical study. All livers underwent 6 hours 
of NMP for viability testing after static cold storage, as 
described previously.28 In brief, livers underwent NMP at 
37°C using a pressure-controlled perfusion device (Liver 
Assist, Groningen, the Netherlands), providing continuous 
portal flow and pulsatile arterial flow. For the preclini-
cal study, informed consent was obtained from relatives 
of the donors and the study protocol was approved by 
the Medical Ethical Committee of the University Medical 
Center Groningen (METc, 2012.068) and by the Dutch 
Transplantation Foundation (NTS). For validation pur-
poses, the identified cutoff values were prospectively 
applied to 6 human livers in an ongoing clinical trial as 
described below.
Histological Analysis
Two biopsies of the common or proper hepatic bile 
duct were collected: one during the back-table procedure 
before NMP and one at the end of NMP (proximally of 
the biliary catheter). All biopsies were fixed in formalin 
and paraffin-embedded. Slides were stained with hema-
toxylin and eosin (H&E) and assessed by light micros-
copy using an established, clinically relevant, histological 
BDI grading system (Table  1).10 The presence of stroma 
necrosis, injury of the extramural peribiliary glands, and 
injury of the perivascular plexus in pretransplant bile duct 
biopsies have been found to predict the development of 
NAS after transplantation.10 For this reason, we selected 
these 3 histological parameters for the present study. The 
range of the total BDI score was 0 to 7 (Table 1). Biopsies 
were independently scored in duplicate by 2 investigators 
(A.P.M.M, and Y.dV.) without knowledge of clinical or 
NMP data under supervision of an expert liver pathologist 
(A.S.H.G.), who resolved any discrepancies between the 
researchers’ scores.
Bile Sample Analyses
During NMP, bile samples were collected every 30 min-
utes under mineral oil (to prevent the exchange of CO2 
between the sample and ambient air, which would influ-
ence the pH and bicarbonate concentration) for immedi-
ate point-of-care determination of pH, bicarbonate and 
glucose concentration using an ABL90 FLEX analyzer 
(Radiometer, Brønhøj, Denmark). Additional bile samples 
were stored at −80°C and later analyzed for LDH using 
routine laboratory technique for standard patient care.
TABLE 1.
Histological BDI scoring systema
Grade Bile duct wall stroma necrosis Extramural peribiliary glands Peribiliary vascular plexus
0 No stroma necrosis No loss or injury of cells No vascular lesions
1 ≤25% stroma necrotic ≤50% loss or injury of cells ≤50% of vessels necrotic
2 >25% and ≤50% stroma necrotic >50% loss or injury of cells >50% of vessels necrotic or no longer visible
3 >50% stroma necrotic  —
aSignificant histological predictors of NAS were selected from op den Dries et al.10
BDI, bile duct injury; NAS, nonanastomotic biliary strictures.
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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Hepatocellular Injury and Function
Alanine aminotransferase (ALT) concentration, lactate 
clearance and bile production are commonly used param-
eters to assess hepatocellular injury and function during 
NMP.11-14 Alanine aminotransferase and lactate concentra-
tions in perfusate were analyzed as described previously.28 A 
peak ALT concentration less than 6000 U/L was considered 
to reflect low hepatocellular injury.14 A lactate concentra-
tion of 2.5 mmol/L or less and cumulative bile production 
of 5 mL/kg liver or greater within 2.5 hours of NMP were 
considered to reflect good hepatocellular function.
Validation Cohort
Identified biomarkers of BDI were subsequently 
included as selection criteria, in addition to hepatocellu-
lar injury and function criteria, in a clinical trial of end-
ischemic NMP for viability assessment of high-risk donor 
livers that were declined for transplantation nationwide 
based on perceived suboptimal quality (www.trialregister.
nl; NTR5972). The study protocol was approved by the 
Medical Ethical Committee (METc 2017.281), and all 
patients gave written informed consent.
Statistics
Continuous variables were presented as median with inter-
quartile range (IQR) and were compared between groups 
using the Mann-Whitney U test. Correlations were calculated 
using the Spearman rank correlation test. Receiver operating 
characteristics (ROC) curves were generated for biliary pH, 
bicarbonate, glucose, and LDH concentration, as well as for 
the bile/perfusate glucose concentration ratio and the delta 
between perfusate and biliary glucose concentration (perfu-
sate minus biliary glucose) to illustrate diagnostic ability of the 
binary BDI score. The first timepoint with an area under the 
ROC curve (AUC-ROC) greater than 0.80 and a P < 0.05 for 
each potential biomarker was selected to determine the cutoff 
value with the highest sensitivity (Sens) and specificity (Spec) 
to discriminate livers with low BDI from those with high 
BDI. Positive predictive value (PPV), negative predictive value 
(NPV), positive likelihood ratio (LR+) and negative likelihood 
ratio (LR−) with corresponding 95% confidence interval (CI) 
were calculated using cross tabulation. Level of significance 
was set at a P value less than 0.05. All statistical analyses were 
performed using IBM SPSS version 23.0 (Chicago, IL).
RESULTS
Donor Liver Characteristics
In the preclinical study, 18 livers were from DCD donors 
and 5 livers were donated after brain death (DBD). The 
overall median (IQR) cold ischemia time was 8.1 hours 
(7.0–9.3 hours) and warm ischemia time (from withdrawal 
of life support until in situ cold flush) in DCD livers was 38 
minutes (33–42 minutes).
Bile Duct Histology
The degree of BDI per histological item in livers with low or 
high BDI is summarized in Table 2. Representative examples 
of H&E staining of bile ducts with low or high BDI are pre-
sented in Figure 1. The median BDI score before NMP was 4.0 
(IQR, 3.0–7.0) and 6.0 (IQR, 6.0–7.0) after NMP, with 8 livers 
showing no change in the BDI score over time. The mean BDI 
score of the 2 biopsies ranged between 3 and 7, with 4.75 as 
the median of the range. This value was chosen to divide livers 
into a group with a low and a group with a high BDI score.
Hepatocellular Function and Injury Correlate Poorly 
With BDI
Overall, there was a weak correlation between peak 
ALT concentration in perfusate during NMP, a marker of 
TABLE 2.
Comparison of BDI score per histological item
 Livers with a low BDI score (n = 9) Livers with a high BDI score (n = 14)
Stroma necrosis (grades 0-3) 2.0 (1.5-2.0) 3.0 (2.6-3.0)
Extramural peribiliary glands (grades 0-2) 1.0 (1.0-1.0) 2.0 (1.5-2.0)
Peribiliary vascular plexus (grades 0-2) 1.0 (1.0-1.5) 2.0 (2.0-2.0)
Variables are presented as median and (IQR).
BDI, bile duct injury; IQR, interquartile range.
FIGURE 1. Representative histological H&E staining of an 
extrahepatic bile duct biopsy with a low histological BDI score (A) and 
a high BDI score (B). A, Intact extramural peribiliary glands (encircled), 
intact vasculature (eg, arrowhead pointing to vital arteriole in stroma) 
and no signs of stroma necrosis. Note that also the periluminal 
peribiliary glands are largely intact. B, Severe injury to the extramural 
peribiliary glands with loss of cells (encircled), necrotic (arrowhead) 
or absent vessels and diffuse stroma necrosis. Note the denuded 
epithelial lining of the bile duct lumen (asterisk), as is the case in >90% 
of all donor bile ducts before transplantation.8-10 BDI, bile duct injury.
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hepatocellular injury, and the degree of BDI (Spearman 
r, 0.424; P = 0.044) (Figure 2A). In livers with extremely 
high ALT levels (>6000 U/L), the BDI score was also 
high in 7 (88%) of 8 cases. However, when ALT lev-
els were less than 6000 U/L and livers could potentially 
be considered for transplantation based on an accept-
able degree of hepatocellular injury,14 the correlation 
between ALT and BDI was very poor (Spearman r, 
0.192; P = 0.493) with 7 (47%) of 15 livers still having 
a high BDI score.
Similarly, 4 (44%) of 9 livers with good lactate clearance 
also had high BDI (Figure  2B). There was no correlation 
between BDI and lactate concentration (Spearman r, 0.349; 
P = 0.103). Likewise, 10 (56%) of 18 livers with high bile 
production also had high BDI. There was no correlation 
between BDI and cumulative bile production (Spearman r, 
−0.291; P = 0.178) (Figure 2C). Furthermore, there was no 
correlation between (cumulative) bile production and bil-
iary pH, bicarbonate, LDH and the glucose and bile/perfu-
sate glucose ratio (Figure S1, SDC, http://links.lww.com/TP/
B649).These findings indicate that markers of hepatocellu-
lar injury and function poorly predicted the degree of BDI, 
especially in cases that could potentially be considered for 
transplantation based on hepatocellular criteria. This sup-
ports the need for specific biomarkers of BDI during NMP.
Biliary pH and Bicarbonate Correlate Significantly 
With BDI
Biliary pH and bicarbonate concentration during NMP 
were significantly higher in livers with low BDI, compared 
with livers with high BDI (Figures  3A-B). As expected, 
biliary pH and bicarbonate were strongly correlated 
(Figure  3C). The line of best fit (R2 = 0.7377) demon-
strated that in the lower range of biliary bicarbonate small 
increases lead to a relatively large increase in pH, whereas 
at higher bicarbonate concentrations (>30 mmol/L), pH 
remained relatively stable.
Because bile production can be low or absent during the 
first 2 hours of NMP, we only used bile samples collected 
after 2 hours to determine optimal cutoff values to dis-
criminate livers with low BDI from those with high BDI 
(Table S1, SDC, http://links.lww.com/TP/B649). Already 
after 2 hours, a biliary bicarbonate concentration of 18 
mmol/L discriminated between low and high BDI with an 
AUC-ROC of 0.91 (P = 0.002) and a Sens, Spec, PPV, NPV 
greater than 80% (Figure 3D-E).
The earliest timepoint at which biliary pH discriminated 
livers with low BDI from those with high BDI was 2.5 
hours (Table S1, SDC, http://links.lww.com/TP/B649). At 
this timepoint, the optimal cutoff value for pH was 7.48, 
with an AUC-ROC of 0.81 (P = 0.019) (Figure 3D-E).
Biliary Glucose and Bile/Perfusate Glucose Ratio 
Correlate Significantly With BDI
Glucose concentrations were lower in bile of livers 
with low BDI, compared with livers with high BDI score 
(Figure 4A). Although biliary glucose gradually decreased 
in livers with low BDI, biliary glucose increased in liv-
ers with high BDI, generally remaining greater than 20 
mmol/L. In livers with high BDI, the median bile/glucose 
concentration ratio increased to 1 and remained stable 
throughout perfusion. In contrast, in livers with low BDI 
the median ratio was always 0.7 or less and gradually 
declined over time (Figure 4B-C). Another way to study 
the relation between biliary and perfusate glucose is by cal-
culating the difference between perfusate and biliary glu-
cose concentration (delta).14 In livers with high BDI, the 
delta was lower compared with livers with low BDI, reach-
ing significance at only 3 and 3.5 hours NMP (Figure 4C). 
After several hours of NMP, negative delta values were 
reached.
The earliest timepoint at which biliary glucose and the 
bile/perfusate glucose ratio could discriminate livers with 
low BDI from those with high BDI was 2 hours (Table S1, 
SDC, http://links.lww.com/TP/B649). At this timepoint, the 
optimal cutoff values were 16 and 0.67 mmol/L, respec-
tively (both AUC 0.82; P = 0.013) (Figure 4F-G). The delta 
between perfusate and biliary glucose did not result in 
an AUC greater than 0.80 at any timepoint, though at 3 
hours NMP an AUC of 0.79 resulted in a cutoff value of 
2.3 mmol/L (P = 0.030, Figure 4F-G, and Table S1, SDC, 
http://links.lww.com/TP/B649).
FIGURE 2. Poor correlation between hepatocellular injury and function and BDI. A, Peak ALT concentration in perfusate during NMP 
correlated poorly with BDI. This was especially true for livers with ALT <6000 U/L, which are potentially transplantable based on this 
hepatocellular criterion, of which nearly half had simultaneous high BDI. Livers with very high ALT (>6000 U/L) frequently had very high 
BDI scores. B, Nearly half of the livers with good lactate clearance, also had a high BDI score. C, There was no correlation between bile 
production and BDI, with over half of livers with high bile production also having high BDI. ALT, alanine aminotransferase; BDI, bile duct 
injury; NMP, normothermic machine perfusion.
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Biliary LDH Correlates Significantly With BDI
Biliary LDH concentration, a marker of biliary epithe-
lial cell injury, was more than twofold higher in livers with 
high BDI, compared with livers with low BDI (Figure 4E). 
In both groups, biliary LDH concentration declined gradu-
ally during NMP. The earliest timepoint with a significant 
AUC-ROC for biliary LDH was 2 hours NMP (Table S1, 
SDC, http://links.lww.com/TP/B649), with an optimal cut-
off value of 3689 U/L and an AUC of 0.83 (P = 0.014) 
(Figures 4F-G).
Clinical Validation of Biliary Biomarkers During NMP
Based on the preclinical research data, we included bil-
iary pH as one of the criteria for hepatobiliary viability 
assessment in a clinical trial of end-ischemic NMP of high-
risk livers that were initially declined nationwide for trans-
plantation. So far, 6 DCD livers (median Eurotransplant 
Donor Risk Index,29 2.9; IQR, 2.7–2.9) have been included 
in this trial of which 4 (median Eurotransplant Donor 
Risk Index, 2.9; IQR, 2.8–3.0; median United Kingdom-
DCD risk score,30 6.0; IQR, 5.8–7.5) met all selection 
criteria for transplantation during NMP, including a bil-
iary pH greater than 7.48 within 2.5 hours of NMP. In 
addition, biliary bicarbonate and glucose bile/perfusate 
ratio were within the ranges identified in the preclinical 
study (Figure 5). The recipients of these 4 liver grafts had 
an uneventful recovery and none of them developed clini-
cal evidence of posttransplant cholangiopathy at a median 
follow-up of 8.3 months (IQR, 7.6–10.1 months). Of the 
2 livers that were declined for transplantation, the first ful-
filled all hepatocellular criteria and was declined only on 
the basis of bile biochemistry (at 2.5 hours NMP: cumula-
tive bile production 45 mL [≥10 mL within 2.5 hours NMP 
and ≥4 mL in preceding hour]; perfusate lactate of 0.3 
mmol/L [<1.7 mmol/L]; perfusate pH 7.38 [7.35–7.45]).
FIGURE 3. Biliary bicarbonate and pH produced during NMP correlated significantly with BDI. Biliary bicarbonate concentration (A) and 
biliary pH (B) were significantly higher in livers with a low BDI score, compared with livers with a high BDI score at each timepoint during 
NMP. C, Biliary pH and bicarbonate concentration were strongly correlated with each other. The line of best fit shows that in the lower 
range of biliary bicarbonate, small increases in biliary bicarbonate led to relatively large increases in biliary pH. At biliary bicarbonate 
greater than 30 mmol/L, biliary pH remained relatively stable despite further increases in bicarbonate concentration. (D) ROC curves 
and (E) statistical analyses of biliary bicarbonate and pH used to discriminate high and low BDI at the earliest timepoints. * P < 0.05. 
More detailed results, including calculations for all timepoints of bile collection during 6 hours of normothermic machine perfusion (NMP), 
are provided in Table S1, SDC (http://links.lww.com/TP/B649). AUC-ROC, area under the ROC curve; BDI, bile duct injury; CI, confidence 
interval; LR, likelihood ratio; NPV, negative predictive value; PPV, positive predictive value; ROC, receiver operating characteristics.
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The second liver was also declined based on hepatocellular 
criteria (cumulative bile production, 57 mL; perfusate lac-
tate, 3.5 mmol/L; perfusate pH, 7.25). At 2.5 hours NMP, 
the perfusate ALT concentration was approximately 4000 
and 6000 U/L, respectively. The retrospectively determined 
median BDI score for the transplanted livers was 3.2 (IQR, 
2.8–3.5) and 4.3 (3.0–5.5) for the nontransplanted livers.
DISCUSSION
In the present study, we have determined the diagnostic 
accuracy of the previously described biomarkers of biliary 
injury and viability, which can be easily assessed point of 
care during ex situ NMP of human donor livers. Biliary 
bicarbonate concentration greater than 18 mmol/L, bil-
iary pH greater than 7.48, biliary glucose concentration 
less than 16 mmol/L, bile/perfusate glucose concentration 
ratio less than 0.67, and biliary LDH concentration less 
than 3689 U/L within 2.5 hours of NMP were strongly 
associated with low histological BDI. These findings have 
important clinical implications as the proposed biomark-
ers allow transplant teams to stratify livers grafts during 
ex situ NMP based on the risk of BDI, and potentially also 
that of posttransplant cholangiopathy. Biliary bicarbonate 
had the highest predictive value out of all of the studied 
biomarkers. This is likely because biliary bicarbonate is 
less influenced by other nonbiliary factors.
Ex situ NMP is increasingly being applied and explored 
as a tool to assess viability of liver grafts that were initially 
declined for transplantation based on a perceived high risk 
of early graft failure.11-14 In most centers, selection criteria 
are currently based on hepatocellular injury and function. 
FIGURE 4. Biliary glucose, bile/perfusate glucose ratio and biliary LDH correlated significantly with BDI during NMP. A, Biliary glucose 
concentration, inversely reflecting biliary epithelial cell function, was significantly lower in livers with low BDI, compared with livers with 
high BDI at nearly each timepoint during NMP. B, In livers with high BDI, the bile/perfusate glucose concentration ratio was higher 
compared with livers with low BDI. C, The delta between perfusate and biliary glucose concentration was lower in livers with high BDI, 
even reaching negative values at the end of NMP. D, Livers with high BDI have relatively higher biliary glucose in relation to perfusate 
glucose concentrations, compared with livers with a low BDI. This resulted in a steeper slope in high BDI livers (slope 0.88), compared 
with low BDI livers (slope, 0.62). E, Biliary LDH concentration, a marker of biliary epithelial cell injury, was significantly higher at each 
timepoint in livers with a high BDI score compared with livers with a low BDI score. (F) ROC curves and (G) Statistical analyses of 
biliary glucose, bile/perfusate glucose ratio, perfusate-biliary glucose delta and biliary LDH used to discriminate high and low BDI at the 
earliest timepoints. * P < 0.05. More detailed results, including calculations for all timepoints of bile collection during 6 hours of NMP, 
are provided in Table S1, SDC (http://links.lww.com/TP/B649). AUC-ROC, area under the ROC curve; BDI, bile duct injury; CI, confidence 
interval; LDH, lactate dehydrogenase; LR, likelihood ratio; NMP, normothermic machine perfusion; NPV, negative predictive value; PPV, 
positive predictive value; ROC, receiver operating characteristics.
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The risk of posttransplant graft failure, however, is not 
only determined by the degree of hepatocellular injury, but 
also by the presence of biliary injury. Especially DCD liv-
ers have an increased risk of developing biliary complica-
tions.31 In a recent clinical study of 12 initially declined 
liver grafts that were identified as transplantable during 
end-ischemic NMP, 25% developed posttransplant chol-
angiopathy despite adequate hepatocellular function dur-
ing pretransplant ex situ NMP.13 These clinical data are 
in line with our observation that some livers with a low 
degree of hepatocellular injury can still have a high degree 
of BDI, which can be missed when no specific biliary viabil-
ity criteria are used. This difference in hepatocellular and 
cholangiocellular injury can be explained by the greater 
susceptibility of cholangiocytes to ischemia-reperfusion 
injury and a slower postischemic recovery of intracellular 
ATP, compared with hepatocytes.23,32
The parameters we have selected as potential biomark-
ers of biliary viability were all based on the known physi-
ological function of healthy bile duct epithelium. Two 
important physiological functions of biliary epithelium 
are active secretion of bicarbonate and reabsorption of 
glucose, leading to an alkalotic pH and very low biliary 
glucose concentrations at the level of the extrahepatic 
bile duct.17,18 We have previously suggested that these 
parameters could potentially serve as biomarkers of bile 
duct viability during machine perfusion.26,33,34 In the cur-
rent study, we demonstrated that biliary pH, bicarbonate 
and glucose concentration indeed strongly correlate with 
histological BDI of liver grafts during NMP, confirming 
observations made earlier this year.14 In 3 independent 
clinical studies, the histological degree of BDI before liver 
transplantation has been identified as a significant predic-
tor of the development of NAS after transplantation.8-10
Our findings suggest that biliary epithelial cells of liv-
ers with high BDI are unable to secrete sufficient amounts 
of bicarbonate to raise the biliary pH. Increasing the bil-
iary pH helps biliary epithelial cells to protect themselves 
against the toxic effects of hydrophobic bile salts, which 
is also known as the “biliary bicarbonate umbrella”.35 
Low biliary pH and bicarbonate, therefore, not only 
reflect biliary injury/dysfunction, but may also contrib-
ute to additional biliary injury due to an absent bicar-
bonate umbrella.36 Biliary pH and bicarbonate were not 
linearly correlated, which is explained by the fact pH var-
ies on a logarithmic scale, whereas bicarbonate does not. 
The pH values we observed in liver grafts with low BDI 
are within the normal range of biliary pH, which var-
ies between 7.5 and 8.1 in the common bile duct.17 The 
same is true for biliary bicarbonate concentration, which 
FIGURE 5. Clinical validation of biliary biomarkers during ex situ NMP of transplanted and nontransplanted livers. Six livers that were 
declined for transplantation nationwide underwent end-ischemic NMP to assess their viability for transplantation in a clinical trial. 
According to protocol, viability assessment occurred within 2.5 hours NMP. Four livers fulfilled the hepatobiliary criteria and were 
transplanted. There was no clinical evidence of posttransplant cholangiopathy at a median of 8.3 months (IQR, 7.6-10.1) follow-up. 
Dotted lines indicate biliary biomarker cutoff values established in the preclinical study. IQR, interquartile range; NMP, normothermic 
machine perfusion.
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normally ranges widely between 12 and 55 mmol/L.18 
Interestingly, Watson et al14 recently reported 3 patients 
that developed cholangiopathy after the transplanta-
tion of livers that were unable to produce bile with a pH 
greater than 7.4 during NMP. This preliminary clinical 
observation is in line with the identified biomarkers of 
BDI in the current study in preclinical livers as well as the 
clinical validation cohort.
Although biliary glucose also correlated significantly 
with the degree of biliary injury, the interpretation of 
glucose values is slightly more complex. Postischemic 
reperfusion of a liver graft almost universally results in 
a pronounced increase of glucose levels in the perfusion 
fluid due to glycogenolysis.37 This contributes to a higher 
glucose concentration in the primary bile produced by 
hepatocytes, which affects the reabsorption of glucose 
from bile when it passes from the canaliculi to the com-
mon bile duct. Even when the biliary epithelium is intact, 
glucose reabsorption via SGLT1 and GLUT1 becomes 
insufficient when biliary glucose concentrations are too 
high, a phenomenon analogous to the renal threshold for 
glucose in kidney tubuli.22,38 In other words, high glucose 
concentration in the perfusion fluid (which is frequently 
seen during NMP) may affect the biliary reabsorption of 
glucose. Biliary glucose levels should therefore be viewed 
in relation to glucose levels in the perfusion fluid. To illus-
trate this, we have correlated glucose concentrations in 
bile with those in the perfusion fluid. The ratio between 
glucose in bile and perfusion fluid was almost 1 in livers 
with high BDI, whereas it was 0.7 or less in livers with low 
BDI. Others have reported the delta between perfusate and 
biliary glucose levels,14 though in our hands this did not 
result in a usable criterion. Our findings regarding biliary 
glucose are in line with an in vitro study with rat cholangi-
ocytes, in which ATP-depleted cholangiocytes showed pro-
longed dysfunction of biliary glucose transporter SGLT1 
and diminished glucose reabsorption.23 Similarly, in an 
experimental study in rabbits, higher glucose concentra-
tions were found in bile of livers that had suffered from 
warm and cold ischemia, compared with livers that had 
not been ischemic.39
The observations made for biliary bicarbonate, pH, and 
glucose were supported by the data on biliary LDH con-
centrations. Based on animal experiments, biliary LDH 
has previously been proposed as a marker of biliary epithe-
lial injury.24 In the current study, biliary LDH was indeed 
significantly higher in livers with high BDI, compared with 
livers with low BDI. In all livers, however, biliary LDH 
concentration declined gradually during NMP, which can 
be explained by an early washout of LDH from dead chol-
angiocytes when bile flow recurs. This is in line with previ-
ous research, where biliary LDH correlated with the length 
of cold ischemia in a rat liver model and previous studies 
that reported lower LDH concentrations in machine per-
fused livers compared with cold stored livers.25,27,40
This study has some limitations. We took biopsies from 
the extrahepatic bile duct to assess the degree of histologi-
cal injury, whereas the intrahepatic bile ducts can also be 
involved in posttransplant cholangiopathy. However, in 
a previous study, we have demonstrated that histologi-
cal injury (in particular injury to the peribiliary vascular 
plexus, extramural peribiliary glands and stroma necro-
sis) assessed at the level of the extrahepatic bile duct also 
reflects the degree of injury in the intrahepatic bile ducts, 
as deep as the segmental bile ducts.41 Furthermore, there 
may have been some degree of sampling error in bile duct 
biopsies. To minimize this, the average BDI of 2 biopsies 
was taken. Furthermore, our preclinical data included 
5 DBD livers, whereas the clinical livers were all DCD. 
However, when we excluded the DBD livers in the preclini-
cal study, similar results were obtained. Lastly, some livers 
produce very little or no recorded bile during NMP. This 
raises the question as to whether or not such livers can 
be transplanted safely. We would advocate an approach 
tailored to the specific donor liver and recipient. For exam-
ple, when assessing a liver with a high risk of develop-
ing NAS, production of good quality bile during NMP 
would be essential to allow cholangiocyte viability assess-
ment before transplantation. On the other hand, for livers 
with a low risk of NAS, cholangiocyte viability assessment 
may not always be necessary, as has been reported in the 
literature.14
Implementation of the identified biomarkers in larger 
clinical trials of NMP with longer follow-up, in which 
both DCD and DBD livers are included, is necessary to 
confirm their utility in decreasing the incidence of post-
transplant cholangiopathy. Machine perfusion has the 
potential to provide opportunities to ameliorate BDI, 
for instance through stem cell therapy. These cholan-
giocellular criteria could be applied to identify livers 
that require additional pharmacological interventions, 
and be used to assess the efficacy of such treatments. In 
conclusion, biliary bicarbonate, pH, glucose, and LDH 
during ex situ NMP are accurate biomarkers of clini-
cally relevant, histological biliary injury of livers grafts. 
These biomarkers can be easily determined point-of-
care, making them suitable for the assessment of bile 
duct viability during NMP and the potential identifica-
tion of donor livers with a low risk of developing post-
transplant cholangiopathy.
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